Neil worked on Wall Street as a healthcare investment banker the first part of his career where he advised biotech and healthcare companies on transactions totaling >$1B, including: IPOs, private placements, public financings, M&A, and in-and-out-licensing of pre-commercial and commercial stage products. After investment banking, Neil transitioned to venture philanthropy and was an integral member of the Executive Leadership Team at the California Institute for Regenerative Medicine (CIRM) where he helped develop the long-term strategic plan to manage and invest $3 billion in the regenerative medicine sector, including cellular, stem cell, and gene therapies. During his time at CIRM, Neil started actively advising and investing in private healthcare companies and founded the investment firm Bioverge Funds Management, LLC to invest in promising early-stage healthcare startups. Bioverge is a premier venture capital firm investing in healthcare startups at the intersection of bio + tech.